Skip to main content
Clinical Trials/NCT00253851
NCT00253851
Completed
Phase 4

Multi-centre, Double-blind, Randomized, Controlled Trial Comparing Intra-operative Regional Heparinization to Placebo for the Prevention of Deep Vein Thrombosis Following Total Knee Arthroplasty

Ottawa Hospital Research Institute1 site in 1 country30 target enrollmentJuly 2003

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
DVT
Sponsor
Ottawa Hospital Research Institute
Enrollment
30
Locations
1
Primary Endpoint
DVT as determined by venography
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

The goal of this study is to prevent blood clots from forming during surgery and a few days after total knee replacement surgery. This study will help us identify whether using a blood thinner in the operating room will stop blood clots from forming during the operation.

Detailed Description

Venous thromboembolism is a major cause of morbidity and mortality after lower limb orthopaedic surgery in the adult patient. If, as suggested, DVT formation begins intra-operatively then targeting this period to prevent clot formation could substantially reduce DVT rates in the TKA population. The present study aims to determine whether this intra-operative regional heparinization technique is effective in preventing the intra-operative formation of DVT following TKA, as evidenced by venography in the early post-operative period.

Registry
clinicaltrials.gov
Start Date
July 2003
End Date
June 2011
Last Updated
14 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Undergoing unilateral primary total knee arthroplasty
  • Males and non-pregnant females ages 18-90 (pre-menopausal females will undergo a serum pregnancy test at screening)
  • Full weight bearing status (of non-operated leg) following surgery
  • Patient able to understand and willing to sign informed consent

Exclusion Criteria

  • Known hypersensitivity to contrast media 2) Patients taking Metformin 3) Serum creatinine above 180Fmol/L 4) Platelets \< 100 x 10 9/L, INR/PTT \> 1.5 x normal 5) History of heparin induced thrombocytopenia 6) Allergy to heparin or fish 7) Prior use of protamine sulfate (i.e., protamine-containing insulin) 8) Vasectomized or infertile males 9) History of bleeding disorder 10) Bilateral total knee arthroplasty 11) History of stroke or myocardial infarction in previous 6 months 12) Traumatic spinal anaesthesia (two or more attempts and/or bloody) 13) History of previous DVT/PE 14) Active peptic ulcer disease (e.g., GI bleed, rectal bleed) 15) Currently on chronic anticoagulant therapy 16) Contra-indication to heparin 17) Patient is taking part in any other investigational study 18) Previous contralateral TKR or hip replacement

Outcomes

Primary Outcomes

DVT as determined by venography

Time Frame: 5 day post op

Secondary Outcomes

  • Bleeding rate Rate of PE Complication Rate(2 week post op)

Study Sites (1)

Loading locations...

Similar Trials